Previous 10 | Next 10 |
Apyx Medical Corporation , formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the ...
Kari Larson Appointed as Senior Director of Clinical Studies; Libet Garber, Ph.D. Appointed as Global Director of Regulatory Affairs Apyx Medical Corporation , formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies an...
Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, which is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in...
Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma ® , a patented surgical product marketed and sold under the Renuvion ® Cosmetic Technology brand in t...
Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma ® , a patented surgical product marketed and sold under the Renuvion ® Cosmetic Technology brand in t...
Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma ® , a patented surgical product marketed and sold under the Renuvion ® Cosmetic Technology brand in t...
Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma ® , a patented surgical product marketed and sold under the Renuvion ® Cosmetic Technology brand in t...
SAN FRANCISCO, June 06, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in ZGNX and APYX of immediately approaching lead plaintiff deadlines in pending securities class actions. Zogenix, Inc. (NASDAQ: ZGNX) CLASS PERIOD: Feb. 6, 2019 - April 8, 2019...
Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma ® , a patented surgical product marketed and sold under the Renuvion ® Cosmetic Technology brand in ...
SAN FRANCISCO, May 29, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, with nine offices in eight cities around the country and eighty attorneys, reminds investors in Apyx Medical Corporation ( NASDAQ: APYX ) of the June 17, 2019 Lead Plaintiff deadline in the securities class a...
News, Short Squeeze, Breakout and More Instantly...
Apyx Medical Corporation Company Name:
APYX Stock Symbol:
NASDAQ Market:
Apyx Medical Corporation Website:
Apyx Medical (NASDAQ: APYX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares...
Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today reported financial results for its first quarter ended March 31, 202...